These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8455434)

  • 1. The use of magnetic resonance imaging to track controlled drug release and transport in the brain.
    Reisfeld B; Blackband S; Calhoun V; Grossman S; Eller S; Leong K
    Magn Reson Imaging; 1993; 11(2):247-52. PubMed ID: 8455434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain distribution of MRI contrast media in rats after intracisternal injection.
    Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G
    J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P
    Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 5. Theory of paramagnetic contrast agents in liposome systems.
    Barsky D; Pütz B; Schulten K; Magin RL
    Magn Reson Med; 1992 Mar; 24(1):1-13. PubMed ID: 1313522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of liposomal gadolinium: in vivo decomplexation.
    Unger EC; Fritz TA; Tilcock C; New TE
    J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paramagnetic dextrans as magnetic resonance blood pool tracers.
    Meyer D; Schaefer M; Chambon C; Beaute S
    Invest Radiol; 1994 Jun; 29 Suppl 2():S90-2. PubMed ID: 7523330
    [No Abstract]   [Full Text] [Related]  

  • 8. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
    Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.
    Kabalka GW; Davis MA; Moss TH; Buonocore E; Hubner K; Holmberg E; Maruyama K; Huang L
    Magn Reson Med; 1991 Jun; 19(2):406-15. PubMed ID: 1881329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning--a comparison of methods.
    Larsson HB; Tofts PS
    Magn Reson Med; 1992 Mar; 24(1):174-6. PubMed ID: 1556924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution and magnetic resonance imaging of cross-linked DTPA polysaccharides.
    Gibby WA; Billings J; Hall J; Ovitt TW
    Invest Radiol; 1990 Feb; 25(2):164-72. PubMed ID: 1690184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride.
    Dean PB; Niemi P; Kivisaari L; Kormano M
    Invest Radiol; 1988 Sep; 23 Suppl 1():S258-60. PubMed ID: 3198357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and chemical forms of gadolinium in the brain: a review.
    Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
    Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.
    Larsson HB; Stubgaard M; Frederiksen JL; Jensen M; Henriksen O; Paulson OB
    Magn Reson Med; 1990 Oct; 16(1):117-31. PubMed ID: 2255233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity of contrast media for magnetic resonance imaging after generalized breakdown of the blood-brain barrier.
    Evill CA; Wilson AJ; Fletcher MC; Sage MR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S336-8. PubMed ID: 8796597
    [No Abstract]   [Full Text] [Related]  

  • 16. Visualization of subtle contrast-related intensity changes using temporal correlation.
    Wood GK; Berkowitz BA; Wilson CA
    Magn Reson Imaging; 1994; 12(7):1013-20. PubMed ID: 7997088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of tissue gadolinium concentration using magnetic resonance imaging: comparison of ultrashort inversion time inversion recovery echoplanar and dynamic three-dimensional spoiled gradient-recalled approaches with in vitro measurements.
    Roberts TP; Brasch RC; Schwickert HC; Shames DM; vanDijke CF; Stiskal M; Mann JS; Mühler A; Demsar F
    Acad Radiol; 1996 Aug; 3 Suppl 2():S282-5. PubMed ID: 8796581
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
    Niemi P; Koskinen S; Reisto T
    Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast anatomical imaging of the heart and assessment of myocardial perfusion with arrhythmia insensitive magnetization preparation.
    Tsekos NV; Zhang Y; Merkle H; Wilke N; Jerosch-Herold M; Stillman A; Uğurbil K
    Magn Reson Med; 1995 Oct; 34(4):530-6. PubMed ID: 8524020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
    Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.